BusinessCascadian Therapeutics Reports Third Quarter 2017 Financial ResultsBy Nasdaq OMXNov 8, 2017, 9:01 PM UTC
BusinessTucatinib Data in Multiple Tumor Types Presented at the European Society for Medical Oncology (ESMO) 2017 CongressBy Nasdaq OMXSep 11, 2017, 10:00 AM UTC
Business2X Oncology Announces Validation of Drug Response Predictor (DRP) for its PARP Inhibitor 2X-121By Nasdaq OMXAug 9, 2017, 2:30 PM UTC
